LON:VEC Vectura Group (VEC) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Vectura Group Stock (LON:VEC) Get Vectura Group alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume203,761 shsAverage Volume3.37 million shsMarket Capitalization£1.01 billionP/E Ratio8.20Dividend Yield23.06%Price TargetN/AConsensus RatingN/A Company Overview Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri, Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta, Anoro Ellipta, and Trelegy Ellipta for the treatment of COPD. It is also developing VR315 (US) for the treatment of asthma and COPD.In addition, the company offers dry powder inhalers, pressurized metered dose inhalers, and nebulized devices. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom. Read More Receive VEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vectura Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VEC Stock News HeadlinesPhilip Morris Intl.'s Vectura Fertin Pharma To Sell Vectura Group To Molex AsiaSeptember 17, 2024 | markets.businessinsider.comPhilip Morris to Sell UK Inhaler Maker Vectura at a LossSeptember 17, 2024 | bloomberg.comFree Stock Pick: The Company First in Line for America’s New Super FuelThe U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by President Trump to deploy a revolutionary new fuel. The first powerplant running this fuel is expected to go live before December 18, 2026. One obscure defense contractor already has a five-year head start on every competitor. The name, ticker symbol, and full story are being revealed at no cost.August 4 at 1:00 AM | Banyan Hill Publishing (Ad)Philip Morris to sell stake in pharma unit Vectura for $198 millionSeptember 17, 2024 | msn.comPhilip Morris unloads Vectura to Molex Asia for $198M in upfront paymentsSeptember 17, 2024 | msn.comPhilip Morris to Take $220 Million Loss on Sale of Inhaled-Medicine UnitSeptember 17, 2024 | wsj.comAptar Pharma Enters into Exclusive Agreement with Pulmotree to Develop and Promote Kolibri™ Non-Propellant Liquid Inhaler PlatformSeptember 10, 2024 | finance.yahoo.comZengun Group AB: Zengun Group AB (publ) Interim Report January - June 2024August 29, 2024 | finanznachrichten.deSee More Headlines VEC Stock Analysis - Frequently Asked Questions How do I buy shares of Vectura Group? Shares of VEC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Vectura Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vectura Group investors own include Hikma Pharmaceuticals (HIK), SEB (SKP), BTG (BTG), iRobot (IRBT), Sinclair Pharma (SPH), Taylor Wimpey (TW). Industry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolLON:VEC CIKN/A Webwww.vectura.com Phone+44-1249-667700FaxN/AEmployees9,200Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio8.20 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio0.77 Current Ratio3.59 Quick Ratio3.20 Sales & Book Value Annual Sales£190.60 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow12.48 Book ValueGBX 91.70 per share Price / BookN/AMiscellaneous Outstanding Shares613,892,000Free FloatN/AMarket Cap£1.01 billion OptionableNot Optionable BetaN/A 7 Stocks That Could Lead the Next Market BoomTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.Get This Free Report This page (LON:VEC) was last updated on 8/4/2026 by MarketBeat.com Staff. From Our Partners"Second Wave” Hitting Iran Soon? Wall Street Issues WarningAnalysts at Goldman Sachs and Morgan Stanley are warning that a quiet domestic threat - unrelated to overseas ...TradeSmith | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | Sponsored1 Stock to Own by July 31stA scheduled announcement on July 31st could reshuffle the stock market's winners and losers - and one lesser-k...Chaikin Analytics | SponsoredFree Stock Pick: The Company First in Line for America’s New Super FuelThe U.S. Army and Department of Energy are launching Project Janus - a high-priority initiative ordered by Pre...Banyan Hill Publishing | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredThis loan shouldn't be possibleOn May 21, 2026, a federal board unanimously approved a roughly 3 billion dollar loan to a single American min...Behind the Markets | Sponsored70% of the Fortune 100 depend on this mystery AI stockSeventy percent of the Fortune 100 already rely on one company's AI cybersecurity platform, which combines mor...The Oxford Club | SponsoredNvidia's CEO says this small device is critical for AI growthA tiny glass device smaller than a fingertip could redefine AI hardware. Nvidia CEO Jensen Huang calls it esse...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vectura Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Vectura Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
